Resverlogix (RVX) Competitors C$0.04 -0.01 (-10.00%) As of 02/21/2025 03:49 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsInsider Trades RVX vs. GSD, IBT, HEM, AEZS, LTY, BCT, ACST, SBM, REUN, and NEPTShould you be buying Resverlogix stock or one of its competitors? The main competitors of Resverlogix include Devonian Health Group (GSD), IBEX Technologies (IBT), Hemostemix (HEM), Aeterna Zentaris (AEZS), Liberty Biopharma (LTY), BriaCell Therapeutics (BCT), Acasti Pharma (ACST), Sirona Biochem (SBM), Reunion Neuroscience (REUN), and Neptune Wellness Solutions (NEPT). These companies are all part of the "biotechnology" industry. Resverlogix vs. Devonian Health Group IBEX Technologies Hemostemix Aeterna Zentaris Liberty Biopharma BriaCell Therapeutics Acasti Pharma Sirona Biochem Reunion Neuroscience Neptune Wellness Solutions Devonian Health Group (CVE:GSD) and Resverlogix (TSE:RVX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, profitability, community ranking, earnings, risk, institutional ownership, dividends and valuation. Which has more risk & volatility, GSD or RVX? Devonian Health Group has a beta of 1.28, suggesting that its stock price is 28% more volatile than the S&P 500. Comparatively, Resverlogix has a beta of 0.71, suggesting that its stock price is 29% less volatile than the S&P 500. Does the media favor GSD or RVX? In the previous week, Devonian Health Group had 2 more articles in the media than Resverlogix. MarketBeat recorded 2 mentions for Devonian Health Group and 0 mentions for Resverlogix. Devonian Health Group's average media sentiment score of 1.13 beat Resverlogix's score of 0.00 indicating that Devonian Health Group is being referred to more favorably in the media. Company Overall Sentiment Devonian Health Group Positive Resverlogix Neutral Is GSD or RVX more profitable? Resverlogix has a net margin of 0.00% compared to Devonian Health Group's net margin of -32.50%. Resverlogix's return on equity of 6.06% beat Devonian Health Group's return on equity.Company Net Margins Return on Equity Return on Assets Devonian Health Group-32.50% -23.31% -8.12% Resverlogix N/A 6.06%-34.90% Does the MarketBeat Community favor GSD or RVX? Resverlogix received 285 more outperform votes than Devonian Health Group when rated by MarketBeat users. Likewise, 84.01% of users gave Resverlogix an outperform vote while only 65.79% of users gave Devonian Health Group an outperform vote. CompanyUnderperformOutperformDevonian Health GroupOutperform Votes2565.79% Underperform Votes1334.21% ResverlogixOutperform Votes31084.01% Underperform Votes5915.99% Which has stronger earnings & valuation, GSD or RVX? Resverlogix has lower revenue, but higher earnings than Devonian Health Group. Devonian Health Group is trading at a lower price-to-earnings ratio than Resverlogix, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDevonian Health GroupC$9.75M3.19-C$3.17M-C$0.02-10.50ResverlogixN/AN/A-C$2.81M-C$0.02-2.23 SummaryDevonian Health Group and Resverlogix tied by winning 6 of the 12 factors compared between the two stocks. Get Resverlogix News Delivered to You Automatically Sign up to receive the latest news and ratings for RVX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RVX vs. The Competition Export to ExcelMetricResverlogixBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$8.91MC$118.00MC$5.84BC$5.70BDividend Yield7.02%3.69%4.75%6.47%P/E Ratio-2.233.2026.1530.24Price / SalesN/A4,826.69435.33480.11Price / Cash132.5013.0138.0182.82Price / Book-0.1947.077.643.84Net Income-C$2.81M-C$87.82MC$3.19BC$298.40M7 Day PerformanceN/A0.38%-2.11%-1.07%1 Month PerformanceN/A3.67%-0.49%1.42%1 Year PerformanceN/A99.17%16.44%38.10% Resverlogix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RVXResverlogixN/AC$0.05-10.0%N/A-30.8%C$8.91MN/A-2.2319Gap DownHigh Trading VolumeGSDDevonian Health GroupN/AC$0.25+25.0%N/A+40.0%C$37.06MC$9.75M-12.506Gap UpHigh Trading VolumeIBTIBEX TechnologiesN/AC$1.44flatN/A+2.1%C$35.54MC$5.77M11.52N/AHEMHemostemixN/AC$0.18-7.7%N/A+118.8%C$26.23MN/A-5.25N/ANews CoverageGap UpAEZSAeterna ZentarisN/AN/AN/AN/AC$25.37MC$2.37M-2.6120LTYLiberty BiopharmaN/AC$2.00+∞N/A+0.0%C$21.54MN/A-12.66N/AGap UpBCTBriaCell TherapeuticsN/AC$7.11+13.6%N/A+31.3%C$18.34MN/A-5.3716Gap UpHigh Trading VolumeACSTAcasti PharmaN/AC$0.58+1.8%N/A+0.0%C$18.19MC$2.71M-1.2132SBMSirona BiochemN/AC$0.07flatN/A-27.8%C$16.69MC$683,768.00-6.50N/AGap DownHigh Trading VolumeREUNReunion NeuroscienceN/AN/AN/AN/AC$16.64MC$4.86M-0.43190Gap DownNEPTNeptune Wellness SolutionsN/AN/AN/AN/AC$15.73MC$48.80M-0.08130Gap Down Related Companies and Tools Related Companies Devonian Health Group Competitors IBEX Technologies Competitors Hemostemix Competitors Aeterna Zentaris Competitors Liberty Biopharma Competitors BriaCell Therapeutics Competitors Acasti Pharma Competitors Sirona Biochem Competitors Reunion Neuroscience Competitors Neptune Wellness Solutions Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:RVX) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$5,000 DOGE check?Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a porti...Altimetry | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Resverlogix Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Resverlogix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
